Unlock instant, AI-driven research and patent intelligence for your innovation.
Application of 3'-deoxyhypoxanthine nucleoside in preparation of medicines, foods or health products for various diseases
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of deoxyinosine and health products, which is applied in the application field of products, and can solve the problems of insufficient therapeutic effect of drugs for treating hyperlipidemia
Pending Publication Date: 2019-01-25
SHENZHEN SUNNY BIO TECH CO LTD
View PDF2 Cites 1 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0004] In order to solve the problem of insufficient therapeutic effect of drugs for treating hyperlipidemia in the prior art, the present invention provides the application of 3'-deoxyinosine in the preparation of food, medicine or health products for preventing or treating hyperlipidemia
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0074] Synthesis of 3'-deoxyinosine:
[0075] Weigh 20.0g of 3'-deoxyadenosine, add 500mL of pure water to dissolve, then add 20.0mg of adenosine deaminase, heat in a water bath at 37°C for 1 hour, and concentrate under reduced pressure and vacuum at 0.07MPa and 40°C to a small amount. Crystals were precipitated, then heated at 37°C to dissolve, and then stood at 4°C for 12 hours to obtain recrystallization and 3'-deoxyinosine (HPLC≥98%)
Embodiment 2
[0077] This test verifies the effect of 3'-deoxyinosine in preventing or treating hyperlipidemia.
[0078] 1. Model preparation
[0079] 20 SD rats, male, clean grade, weighing 180-200 g, were purchased from the Experimental Animal Center of the Academy of Military Medical Sciences of the Chinese People's Liberation Army, and the experimental animal use license number is SCXK2015-0001. Rat diet standard feed (LAD0020, Nantong Trofe), rat 60% high-fat diet (mixed hyperlipidemia model feed, Nantong Trofe).
[0080] After the rats were fed adaptively for one week, they were weighed, and 20 experimental animals were randomly divided into 2 groups, 10 in each group. The blank control group was given diet, and the model group was given high-fat feed. After continuous feeding for 4 weeks, fasting After 12 hours, the rats were weighed 1 hour after the last administration, and blood was collected by docking the tail.
[0081] The blood was placed at room temperature for 2 hours, cent...
Embodiment 3
[0090] This experiment verified the effect of 3'-deoxyinosine in preventing or treating food-induced obesity.
[0091] 1. Test animals and feed
[0092] Thirty SD rats, male, clean grade, weighing 180-200 g, were purchased from the Experimental Animal Center of the Academy of Military Medical Sciences of the Chinese People's Liberation Army, and the license number for the use of experimental animals is SCXK2015-0001. Rat diet standard feed (LAD0020, Nantong Trofe), rat 60% high-fat diet (Research diets D12492, 60% cal, USA, Research Diets).
[0093] 2. Modeling of rats with food-induced obesity
[0094] After the rats were fed adaptively for one week, they were weighed, and 20 experimental animals were randomly divided into 2 groups, 10 in each group. The blank control group was given diet, and the model group was given high-fat feed. After continuous feeding for 4 weeks, fasting 12 hours later, weighed 1 hour after the last administration, docked the tail to take blood, pla...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The present invention relates to the field of pharmaceuticals and provides the application of 3'-deoxyhypoxanthine nucleosides in the preparation of foods, medicines or health products for the prevention or treatment of food-borne obesity or hyperlipidemia provides, provides the application of 3'-deoxyhypoxanthine nucleosides in the preparation of foods, medicines or health products for the prevention of hypertension or arteriosclerosis, and also provides the application of 3'-deoxyhypoxanthine nucleoside in preparation of skin care products. A study of that present invention show that the 3'-deoxyhypoxanthine nucleosides have significant therapeutic effect on hyperlipidemia, reduces the body weight of foodborne obesity, and overcomes the existing technical bias. And the 3'-deoxyhypoxanthine nucleosides have a more comprehensive efficacy in the prevention or treatment of hyperlipidemia than the existing drugs. And the 3'-deoxyhypoxanthine nucleoside can effectively prevent the occurrence of hypertension and arteriosclerosis by decreasing the content of lipid and high densitylipoprotein in serum.
Description
technical field [0001] The invention relates to the technical field of medicines, in particular to the application of 3'-deoxyinosine in the preparation of food, medicine or health products for the prevention or treatment of hyperlipidemia and food-induced obesity. 3'-deoxyinosine The application of nucleosides in the preparation of food, medicine or health products for preventing hypertension or arteriosclerosis, and the application of 3'-deoxyinosine nucleoside in the preparation of skin care products. Background technique [0002] About 12 million people die of cardiovascular and cerebrovascular diseases every year in the world, and hyperlipidemia is one of the main causes of cardiovascular and cerebrovascular diseases. There are as many as 160 million hyperlipidemia patients in China. Hyperlipidemia damages the body insidiously, gradually, progressively and systemically. Its direct damage is to accelerate systemic atherosclerosis, which in turn leads to numerous related...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.